Your browser doesn't support javascript.
loading
HTLV seroprevalence in people using HIV pre-exposure prophylaxis in England.
Bradshaw, Daniel; Khawar, Arham; Patel, Poorvi; Tosswill, Jennifer; Brown, Colin; Ogaz, Dana; Mason, Emily; Osman, Roeann; Mitchell, Holly; Dosekun, Olamide; Peris, Borja Mora; Pickard, Graham; Rayment, Michael; Jones, Rachael; Hopkins, Mark; Williams, Andy; Kingston, Margaret; Machin, Nicholas; Taha, Yusri; Duncan, Sarah; Turner, Neil; Gill, Noel; Andrews, Nick; Raza, Mohammad; Tazzyman, Simon; Nori, Achyuta; Cunningham, Emma; Taylor, Graham P.
Afiliación
  • Bradshaw D; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK; National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London W2 1NY, UK. Electronic address: daniel.bradshaw@ukhsa.gov.uk.
  • Khawar A; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Patel P; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Tosswill J; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Brown C; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ogaz D; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Mason E; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Osman R; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Mitchell H; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Dosekun O; Imperial College Healthcare NHS Trust, St Mary's Hospital, London W2 1NY, UK.
  • Peris BM; Imperial College Healthcare NHS Trust, St Mary's Hospital, London W2 1NY, UK.
  • Pickard G; Imperial College Healthcare NHS Trust, St Mary's Hospital, London W2 1NY, UK.
  • Rayment M; Chelsea and Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK.
  • Jones R; Chelsea and Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK.
  • Hopkins M; Barts Health NHS Trust, St Bartholomew's Hospital, London EC1A 7BE, UK.
  • Williams A; Barts Health NHS Trust, St Bartholomew's Hospital, London EC1A 7BE, UK.
  • Kingston M; Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
  • Machin N; Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
  • Taha Y; Newcastle Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle NE1 4LP, UK.
  • Duncan S; Newcastle Hospitals NHS Foundation Trust, Queen Victoria Road, Newcastle NE1 4LP, UK.
  • Turner N; Chelsea and Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK.
  • Gill N; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Andrews N; UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Raza M; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK.
  • Tazzyman S; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield S10 2JF, UK.
  • Nori A; Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.
  • Cunningham E; Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK.
  • Taylor GP; Imperial College London, London W2 1PG, UK; National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London W2 1NY, UK.
J Infect ; 86(3): 245-247, 2023 03.
Article en En | MEDLINE | ID: mdl-36773896
ABSTRACT

OBJECTIVES:

HTLV-1 is predominantly a sexually-transmitted infection but testing is not mentioned in HIV-PrEP guidelines. We ascertained HTLV-1/HTLV-2 seroprevalence amongst HIV-PrEP users in England.

METHODS:

An unlinked anonymous seroprevalence study.

RESULTS:

Amongst 2015 HIV-PrEP users, 95% were men, 76% of white ethnicity and 83% had been born in Europe. There were no HTLV-1/HTLV-2 seropositive cases (95% confidence interval 0% - 0.18%).

CONCLUSIONS:

There were no HTLV positive cases, likely reflecting the demographic of mostly white and European-born individuals. Similar studies are needed worldwide to inform public health recommendations for HIV-PrEP using populations, particularly in HTLV-endemic settings.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de Transmisión Sexual / Infecciones por VIH / Profilaxis Pre-Exposición Límite: Humans / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de Transmisión Sexual / Infecciones por VIH / Profilaxis Pre-Exposición Límite: Humans / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2023 Tipo del documento: Article